Skip to main content
. 2022 Dec 6;7(50):47225–47238. doi: 10.1021/acsomega.2c06455

Table 2. Cytotoxicity, Leishmania Antiamastigote Activity, and Selectivity Indexes of Active Derivatives 3a–f.

  compounds peritoneal macrophage, CC50 (μM) J774.1A macrophage, CC50 (μM) amastigote, IC50 (μM) L. braziliensis (S.I.Leishmania)a epimastigote, IC50 (μM) T. cruzi (S.I.T.cruzi)b
1 3a 61.02 ± 2.34 90.20 ± 4.32 8.26 ± 0.45 (7.4) <3.6
2 3b >100.0 >120.00 7.41 ± 0.39 (>13.5) >6.7
3 3c 89.86 ± 3.77 104.78 ± 5.66 8.96 ± 0.53 (10.0) 9.1
4 3d 77.98 ± 3.89 78.59 ± 3.99 12.67 ± 0.78 (6.2) 5.5
5 3e 84.76 ± 3.67 114.58 ± 5.43 13.99 ± 0.89 (6.1) 6.4
6 3f >100.0 >120.0 8.43 ± 0.51 (>11.9) no active
7 miltefosine 67.78 ± 3.11 72.34 ± 3.45 21.23 ± 1.13 (3.2)  
8 glucantime 138.22 ± 10.11   12.21 ± 2.12 (11.3)  
9 nifurtimox   280.0 ± 4.00c   36c
a

Selectivity indexes calculated from ratio between the CC50 (peritoneal macrophage) and IC50 (amastigotes of L. braziliensis).

b

Selectivity indexes calculated from the ratio between the CC50 (J774.1A) and IC50 of epimastigotes (T. cruzi).

c

From ref (36).